03-04 Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2024 CI
03-04 Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
12-18 Parnell Pharmaceuticals Holdings Ltd has entered into an agreement to acquire Noble Pharma, LLC. CI
31/01/25 RCBC BidCo Pty Ltd proposed to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F). CI
21/06/22 Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
28/01/21 DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million CI
21/12/20 DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million. CI
23/09/20 Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray CI
14/10/19 Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019 CI
05/04/19 Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019 CI
02/11/18 Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018 CI
03/08/18 Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018 CI
28/04/18 Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018 CI
Manager TitleAgeSince
Chief Executive Officer 50 09/01/2018
Chief Tech/Sci/R&D Officer - 01/09/2021
Chief Operating Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 50 -
Chairman 69 01/01/2006
Director/Board Member - 21/12/2020
Logo Parnell Pharmaceuticals Holdings Ltd
Parnell Pharmaceuticals Holdings Ltd is an Australia-based company, which is engaged in offering the global veterinary pharmaceutical business marketing products in 14 countries. The Company operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The Company also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.
Employees
-
Sector
-